Literature DB >> 13953647

Identification of a 6,21-dihydroxylated metabolite of medroxyprogesterone acetate in human urine.

M L HELMREICH, R A HUSEBY.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS; MEDROXYPROGESTERONE

Mesh：

Substances：

Year:  1962        PMID： 13953647     DOI： 10.1210/jcem-22-10-1018

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.

Authors:  S Lundgren; P E Lønning; A Aakvaag; S Kvinnsland
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.

Authors:  Salndave B Skosana; John G Woodland; Meghan Cartwright; Kim Enfield; Maleshigo Komane; Renate Louw-du Toit; Zephne van der Spuy; Chanel Avenant; Donita Africander; Karl-Heinz Storbeck; Janet P Hapgood
Journal:  J Steroid Biochem Mol Biol       Date:  2019-02-26       Impact factor: 4.292

3.  Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients.

Authors:  H van Veelen; P H Willemse; D T Sleijfer; J J Pratt; W J Sluiter; H Doorenbos
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer.

Authors:  H C Blossey; H H Bartsch; D Kanne; J Koebberling; G A Nagel
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 5.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.